We are pleased to announce that we have recently received two prestigious awards for our Minuteful Kidney solution.
Minuteful Kidney was named the platinum winner for ‘Best Digital Diagnostics Solution’ in the Digital Health Innovation category at the Juniper Research Future Digital Awards 2023. The Juniper awards highlight technology companies at the forefront of their respective fields and evaluate the impact of cutting-edge solutions within each market sector. The Digital Health Innovation awards aim to recognize the most innovative products and services in the wake of an unprecedented year of change for the healthcare industry, rewarding cutting-edge technology that pushes the healthcare boundaries. Our Minuteful Kidney test does just that.
We were also named the winner of the Best In-Home Testing Solution in the 2023 MedTech Breakthrough Awards for Digital Health. This award recognizes our use of innovative technology to improve the quality and accessibility of healthcare. “Healthy.io’s Minuteful Kidney is a breakthrough solution that is also redefining telehealth, as a bridge for healthcare providers to connect and engage with their patients beyond a video call,” said James Johnson, managing director, MedTech Breakthrough. “The seamless transference between at-home results and healthcare providers—created by Healthy.io’s breakthrough innovators—is vital to today’s digital world, increasing patient engagement for doctors and convenience for patients.”
"We are honored to be recognized by Juniper Research and the MedTech Breakthrough Awards for our work in digital diagnostics. This recognition validates our commitment to using technology to make healthcare more accessible and affordable for everyone."
Ron Zohar, Chief Product Officer, Healthy.io
We are thrilled that Juniper Research and MedTech have recognized our work to date and we are excited to continue to innovate and improve our digital diagnostics solutions. We believe that our technology has the potential to make a real difference in the lives of people with chronic diseases, and we are committed to making it accessible to everyone.